Sign in Sign up for free

Free Stock Screener

Load
Save
Create a watchlist Help
 
–
×
–
×
–
×
–
×
–
×
–
×
–
×
–
day ×
–
day ×
–
% ×
–
% ×
×
–
×
–
×
–
×
–
×
–
×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
day ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
×
–
% ×
–
×
–
×
–
% ×
–
×
–
×
–
×
–
×
–
×

ABEO
Abeona Therapeutics Inc
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Current assets
Cash $34.764 $17.896 $14.811 $5.05
Short term investments $88.282 $44.786 $37.753 $49.042
Net receivables $1.64 $2.232 $2.444 $2.209
Inventory
Total current assets $125.904 $66.725 $55.737 $57.264
Long term investments
Property, plant & equipment $7.999 $7.989 $7.988 $8.684
Goodwill & intangible assets
Total noncurrent assets $8.099 $8.103 $8.265 $8.823
Total investments $88.282 $44.786 $37.753 $49.042
Total assets $134.003 $74.828 $64.002 $66.087
Current liabilities
Accounts payable $3.099 $3.362 $1.858 $7.064
Deferred revenue
Short long term debt $4.014 $1.044 $0.998 $1.649
Total current liabilities $16.843 $11.889 $13.422 $8.412
Long term debt $19.151 $22.125 $4.402 $4.043
Total noncurrent liabilities $43.919 $71.82 $35.754 $35.637
Total debt $23.165 $23.169 $5.4 $5.692
Total liabilities $60.762 $83.709 $49.176 $44.049
Stockholders' equity
Retained earnings -$773.696 -$781.102 -$749.524 -$732.933
Other stockholder equity -$0.134 -$0.184 -$0.066 -$0.099
Total stockholder equity $73.241 -$8.881 $14.826 $22.038
(in millions USD) 2023 2022 2021
Current assets
Cash $14.811 $14.555 $32.938
Short term investments $37.753 $37.932 $12.086
Net receivables $2.444 $0.188 $3
Inventory
Total current assets $55.737 $53.099 $55.401
Long term investments
Property, plant & equipment $7.988 $11.072 $21.742
Goodwill & intangible assets $1.384
Total noncurrent assets $8.265 $11.115 $24.185
Total investments $37.753 $37.932 $12.086
Total assets $64.002 $64.214 $79.586
Current liabilities
Accounts payable $1.858 $5.974 $8.153
Deferred revenue $0.296
Short long term debt $0.998 $1.773 $1.818
Total current liabilities $13.422 $7.779 $16.623
Long term debt $4.402 $5.854 $7.56
Total noncurrent liabilities $35.754 $29.674 $11.588
Total debt $5.4 $7.627 $9.378
Total liabilities $49.176 $37.453 $28.211
Stockholders' equity
Retained earnings -$749.524 -$695.336 -$655.64
Other stockholder equity -$0.066 -$0.129 -$0.027
Total stockholder equity $14.826 $26.761 $51.375

Income statement

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Revenue
Total revenue
Cost of revenue
Gross profit
Operating activities
Research & development $9.218 $7.207 $7.379 $7.148
Selling, general & administrative $8.646 $7.123 $5.83 $4.156
Total operating expenses $17.864 $14.33 $13.209 $11.304
Operating income -$17.864 -$14.33 -$13.209 -$11.304
Income from continuing operations
EBIT $8.478 -$30.626 -$16.482 -$11.731
Income tax expense
Interest expense $1.072 $0.952 $0.109 $0.105
Net income
Net income $7.406 -$31.578 -$16.591 -$11.836
Income (for common shares) $7.406 -$31.578 -$16.591 -$11.836
(in millions USD) 2023 2022 2021
Revenue
Total revenue $3.5 $1.414 $3
Cost of revenue
Gross profit $3.5 $1.414 $3
Operating activities
Research & development $31.091 $28.965 $34.325
Selling, general & administrative $19.004 $17.256 $22.795
Total operating expenses $49.03 $51.879 $92.836
Operating income -$45.53 -$50.465 -$89.836
Income from continuing operations
EBIT -$53.77 -$38.96 -$81.266
Income tax expense
Interest expense $0.418 $0.736 $3.67
Net income
Net income -$54.188 -$39.696 -$84.936
Income (for common shares) -$54.188 -$43.478 -$84.936

Cash flows

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Net income $7.406 -$31.578 -$16.591 -$11.836
Operating activities
Depreciation $0.685 $0.724 $0.721 $0.751
Business acquisitions & disposals
Stock-based compensation $1.323 $1.546 $1.514 $1.557
Total cash flows from operations -$12.684 -$14.538 -$9.235 -$5.746
Investing activities
Capital expenditures -$0.693 -$0.725 -$0.02 -$0.036
Investments -$43.439 -$7.092 $11.549 -$18.707
Total cash flows from investing -$44.132 -$7.817 $11.529 -$18.743
Financing activities
Dividends paid
Sale and purchase of stock $73.684 $6.403 $7.617 $22.976
Net borrowings $19.037 -$0.15
Total cash flows from financing $73.684 $25.44 $7.467 $22.976
Effect of exchange rate
Change in cash and equivalents $16.868 $3.085 $9.761 -$1.513
(in millions USD) 2023 2022 2021
Net income -$54.188 -$39.696 -$84.936
Operating activities
Depreciation $3.198 $4.577 $4.464
Business acquisitions & disposals
Stock-based compensation $4.768 $3.051 $8.916
Total cash flows from operations -$37.009 -$43.483 -$65.665
Investing activities
Capital expenditures -$0.127 $1.604 -$4.151
Investments $0.335 -$25.568 $70.213
Total cash flows from investing $0.208 -$23.964 $66.062
Financing activities
Dividends paid
Sale and purchase of stock $37.207 $46.955 $26.315
Net borrowings -$0.15
Total cash flows from financing $37.057 $43.173 $24.861
Effect of exchange rate
Change in cash and equivalents $0.256 -$24.274 $25.258

ACIU
AC Immune SA
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions CHF) 29 Sep 2022 29 Jun 2022 30 Mar 2022 30 Dec 2021
Current assets
Cash CHF44.503 CHF63.147 CHF57.835 CHF82.216
Short term investments CHF96 CHF91 CHF116 CHF116
Net receivables CHF4.211 CHF0.768 CHF0.418 CHF1.403
Inventory
Other current assets
Total current assets CHF147.602 CHF158.38 CHF177.058 CHF202.634
Long term investments
Property, plant & equipment CHF7.178 CHF7.629 CHF7.682 CHF8.03
Goodwill
Intangible assets CHF50.416 CHF50.416 CHF50.416 CHF50.416
Other assets CHF0.361 CHF0.361 CHF0.363 CHF0.363
Total assets CHF205.557 CHF216.786 CHF235.519 CHF261.443
Current liabilities
Accounts payable CHF1.519 CHF0.337 CHF0.501 CHF2.003
Short long term debt
Other current liabilities CHF0.524 CHF0.425 CHF0.266 CHF0.717
Total current liabilities CHF13.6 CHF11.924 CHF11.911 CHF20.026
Long term debt
Other liabilities CHF7.281 CHF7.098
Minority interest
Total liabilities CHF15.503 CHF13.974 CHF21.388 CHF29.464
Stockholders' equity
Common stock CHF1.797 CHF1.796 CHF1.795 CHF1.794
Retained earnings -CHF242.994 -CHF230.169 -CHF218.793 -CHF200.942
Treasury stock -CHF0.052 -CHF0.075 -CHF0.124 -CHF0.124
Capital surplus CHF431.303 CHF431.26 CHF431.253 CHF431.251
Total stockholder equity CHF190.054 CHF202.812 CHF214.131 CHF231.979
Net tangible assets CHF139.638 CHF152.396 CHF163.715 CHF181.563
(in millions CHF) 2021 2020 2019
Current assets
Cash CHF82.216 CHF160.893 CHF193.587
Short term investments CHF116 CHF65 CHF95
Net receivables CHF1.403 CHF1.9 CHF1.329
Inventory
Other current assets CHF0.02 CHF0.07
Total current assets CHF202.634 CHF231.767 CHF292.774
Long term investments
Property, plant & equipment CHF8.03 CHF6.639 CHF6.172
Goodwill
Intangible assets CHF50.416
Other assets CHF0.363 CHF0.334 CHF0.304
Total assets CHF261.443 CHF238.74 CHF299.25
Current liabilities
Accounts payable CHF2.003 CHF2.184 CHF0.142
Short long term debt CHF0.652
Other current liabilities CHF0.717 CHF0.306 CHF4.477
Total current liabilities CHF20.026 CHF14.018 CHF17.51
Long term debt
Other liabilities CHF7.098 CHF7.464 CHF7.485
Minority interest
Total liabilities CHF29.464 CHF23.262 CHF26.808
Stockholders' equity
Common stock CHF1.794 CHF1.538 CHF1.437
Retained earnings -CHF200.942 -CHF132.85 -CHF75.521
Treasury stock -CHF0.124 -CHF0.1
Capital surplus CHF431.251 CHF346.89 CHF346.526
Total stockholder equity CHF231.979 CHF215.478 CHF272.442
Net tangible assets CHF181.563 CHF215.478 CHF272.442

Income statement

XSLX
XSLX
(in millions CHF) 29 Sep 2022 29 Jun 2022 30 Mar 2022 30 Dec 2021
Revenue
Total revenue CHF3.934
Cost of revenue CHF14.385 CHF15.123 CHF20.124
Gross profit -CHF10.451 -CHF15.123 -CHF20.124
Operating activities
Research & development CHF15.692 CHF15.123 CHF15.123
Selling, general & administrative CHF3.274 CHF4.374 CHF4.166 CHF3.662
Total operating expenses CHF17.397 CHF19.859 CHF18.83 CHF23.532
Operating income -CHF13.463 -CHF19.859 -CHF18.83 -CHF23.532
Income from continuing operations
Net other income -CHF0.049 CHF0.219 -CHF0.014 CHF2.259
EBIT -CHF13.463 -CHF19.859 -CHF18.83 -CHF23.532
Income before tax -CHF13.512 -CHF19.64 -CHF18.844 -CHF21.273
Income tax expense CHF0.004 CHF0.003 CHF0.004 CHF0.003
Minority interest
Net income
Net income -CHF13.516 -CHF19.643 -CHF18.848 -CHF21.276
Income (for common shares) -CHF13.516 -CHF19.643 -CHF18.848 -CHF21.276
(in millions CHF) 2021 2020 2019
Revenue
Total revenue CHF15.431 CHF110.456
Cost of revenue CHF62.282 CHF59.487 CHF50.432
Gross profit -CHF62.282 -CHF44.056 CHF60.024
Operating activities
Research & development
Selling, general & administrative CHF17.91 CHF18.557 CHF16.058
Total operating expenses CHF79.01 CHF76.691 CHF65.92
Operating income -CHF79.01 -CHF61.26 CHF44.536
Income from continuing operations
Net other income CHF6.017 -CHF0.661 CHF0.906
EBIT -CHF79.01 -CHF61.26 CHF44.536
Income before tax -CHF72.993 -CHF61.921 CHF45.442
Income tax expense CHF0.003
Minority interest
Net income
Net income -CHF72.996 -CHF61.921 CHF45.442
Income (for common shares) -CHF72.996 -CHF61.921 CHF45.442

Cash flows

XSLX
XSLX
(in millions CHF) 29 Sep 2022 29 Jun 2022 30 Mar 2022 30 Dec 2021
Net income -CHF13.516 -CHF19.643 -CHF18.848 -CHF21.276
Operating activities
Depreciation CHF0.579 CHF0.575 CHF0.6 CHF0.628
Change in accounts receivable -CHF3.895 -CHF0.069 CHF0.162 -CHF0.088
Changes in inventory
Total cash flows from operations -CHF13.537 -CHF19.481 -CHF23.143 -CHF17.828
Investing activities
Capital expenditures -CHF0.121 -CHF0.537 -CHF0.54 -CHF0.722
Investments -CHF5 CHF25 CHF25 -CHF21
Other cash flows from investing CHF0.002 CHF0.002 CHF0.002
Total cash flows from investing -CHF5.121 CHF24.465 -CHF0.54 -CHF21.722
Financing activities
Dividends paid
Net borrowings -CHF0.143 -CHF0.142 -CHF0.141 CHF23.319
Other cash flows from financing -CHF0.775 -CHF0.006
Total cash flows from financing -CHF0.142 -CHF0.137 -CHF0.916 CHF28.733
Effect of exchange rate CHF0.156 CHF0.465 CHF0.218 -CHF0.551
Change in cash and equivalents -CHF18.644 CHF5.312 -CHF24.381 -CHF11.368
(in millions CHF) 2021 2020 2019
Net income -CHF72.996 -CHF61.921 CHF45.442
Operating activities
Depreciation CHF2.406 CHF1.967 CHF1.694
Change in accounts receivable -CHF0.099 -CHF0.025 -CHF0.068
Changes in inventory
Total cash flows from operations -CHF65.689 -CHF59.517 CHF55.22
Investing activities
Capital expenditures -CHF2.635 -CHF1.706 -CHF1.885
Investments -CHF51 CHF30 -CHF65
Other cash flows from investing -CHF0.029 -CHF0.029 -CHF0.029
Total cash flows from investing -CHF53.664 CHF28.329 -CHF66.885
Financing activities
Dividends paid
Net borrowings CHF22.95 -CHF0.946 CHF50.057
Other cash flows from financing -CHF0.006 -CHF0.006 -CHF0.51
Total cash flows from financing CHF40.746 -CHF0.803 CHF49.616
Effect of exchange rate -CHF0.07 -CHF0.703 -CHF0.826
Change in cash and equivalents -CHF78.677 -CHF32.694 CHF37.125

ARAY
Accuray Inc
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 31 Mar 2024 31 Dec 2023 30 Sep 2023 30 Jun 2023
Current assets
Cash $62.154 $74.492 $78.691 $91.202
Short term investments
Net receivables $73.154 $77.397 $77.37 $74.777
Inventory $159.566 $155.228 $149.977 $145.15
Total current assets $313.91 $331.17 $334.147 $338.033
Long term investments $13.586 $14.536 $13.121 $15.128
Property, plant & equipment $54.514 $49.013 $49.341 $46.779
Goodwill & intangible assets $57.752 $57.887 $57.819 $57.891
Total noncurrent assets $148.617 $145.18 $142.683 $141.181
Total investments $13.586 $14.536 $13.121 $15.128
Total assets $462.527 $476.35 $476.83 $479.214
Current liabilities
Accounts payable $44.43 $39.18 $34.877 $33.739
Deferred revenue $97.358 $102.215 $98.703 $99.264
Short long term debt $12.527 $12.445 $12.306 $9.872
Total current liabilities $198.39 $209.306 $201.449 $198.637
Long term debt $194.463 $189.778 $192.598 $195.164
Total noncurrent liabilities $223.056 $219.391 $224.437 $226.918
Total debt $206.99 $202.223 $204.904 $205.036
Total liabilities $421.446 $428.697 $425.886 $425.555
Stockholders' equity
Retained earnings -$521.068 -$514.726 -$505.105 -$502.136
Other stockholder equity -$1.908 $1.057 -$1.716 $0.422
Total stockholder equity $41.081 $47.653 $50.944 $53.659
(in millions USD) 2023 2022 2021
Current assets
Cash $91.202 $90.154 $118.201
Short term investments
Net receivables $74.777 $94.442 $85.36
Inventory $145.15 $142.254 $125.929
Total current assets $338.033 $350.89 $352.773
Long term investments $15.128 $13.879 $15.935
Property, plant & equipment $46.779 $29.483 $34.854
Goodwill & intangible assets $57.891 $58.09 $58.395
Total noncurrent assets $141.181 $121.959 $127.325
Total investments $15.128 $13.879 $15.935
Total assets $479.214 $472.849 $480.098
Current liabilities
Accounts payable $33.739 $31.337 $19.467
Deferred revenue $99.264 $100.069 $105.345
Short long term debt $9.872 $17.13 $11.959
Total current liabilities $198.637 $208.858 $192.359
Long term debt $195.164 $182.36 $187.448
Total noncurrent liabilities $226.918 $210.802 $218.899
Total debt $205.036 $199.49 $199.407
Total liabilities $425.555 $419.66 $411.258
Stockholders' equity
Retained earnings -$502.136 -$492.522 -$488.024
Other stockholder equity $0.422 $2.406 $2.093
Total stockholder equity $53.659 $53.189 $68.84

Income statement

XSLX
XSLX
(in millions USD) 31 Mar 2024 31 Dec 2023 30 Sep 2023 30 Jun 2023
Revenue
Total revenue $101.132 $107.238 $103.892 $118.292
Cost of revenue $72.058 $71.336 $64.399 $80.614
Gross profit $29.074 $35.902 $39.493 $37.678
Operating activities
Research & development $10.909 $15.281 $14.013 $14.187
Selling, general & administrative $22.727 $24.585 $23.267 $23.948
Total operating expenses $33.636 $39.866 $37.28 $38.135
Operating income -$4.562 -$3.964 $2.213 -$0.457
Income from continuing operations
EBIT -$5.898 -$8.743 -$1.037 -$1.976
Income tax expense $0.444 $0.878 $1.932 $0.58
Interest expense
Net income
Net income -$6.342 -$9.621 -$2.969 -$2.556
Income (for common shares) -$6.342 -$9.621 -$2.969 -$2.556
(in millions USD) 2023 2022 2021
Revenue
Total revenue $447.605 $429.909 $396.289
Cost of revenue $293.645 $269.954 $236.782
Gross profit $153.96 $159.955 $159.507
Operating activities
Research & development $57.129 $57.752 $52.729
Selling, general & administrative $94.449 $94.055 $84.543
Total operating expenses $151.578 $151.807 $137.272
Operating income $2.382 $8.148 $22.235
Income from continuing operations
EBIT -$6.788 -$2.002 -$4.559
Income tax expense $2.492 $3.345 $1.752
Interest expense
Net income
Net income -$9.28 -$5.347 -$6.311
Income (for common shares) -$9.28 -$5.347 -$6.311

Cash flows

XSLX
XSLX
(in millions USD) 31 Mar 2024 31 Dec 2023 30 Sep 2023 30 Jun 2023
Net income -$6.342 -$9.621 -$2.969 -$2.556
Operating activities
Depreciation $1.601 $1.546 $1.251 $1.097
Business acquisitions & disposals $0.059
Stock-based compensation $2.735 $2.314 $2.392 $2.452
Total cash flows from operations -$8.102 -$5.093 -$8.591 $8.881
Investing activities
Capital expenditures -$0.795 -$1.249 -$1.092 -$8.035
Investments
Total cash flows from investing -$0.795 -$1.249 -$1.092 -$7.976
Financing activities
Dividends paid
Sale and purchase of stock $1.36 $1.061
Net borrowings -$1.5 -$1.5 -$1.5 -$1.5
Total cash flows from financing -$1.5 -$0.257 -$1.5 -$0.522
Effect of exchange rate -$1.941 $2.4 -$1.328 -$0.031
Change in cash and equivalents -$12.338 -$4.199 -$12.511 $0.352
(in millions USD) 2023 2022 2021
Net income -$9.28 -$5.347 -$6.311
Operating activities
Depreciation $4.527 $5.513 $6.389
Business acquisitions & disposals -$0.079
Stock-based compensation $10.053 $10.6 $9.332
Total cash flows from operations $15.539 -$2.4 $38.512
Investing activities
Capital expenditures -$12.614 -$4.717 -$2.32
Investments
Total cash flows from investing -$12.681 -$4.717 -$2.399
Financing activities
Dividends paid
Sale and purchase of stock $2.2 $3.889 -$11.05
Net borrowings -$4.113 -$19 -$17.412
Total cash flows from financing -$2.112 -$15.369 -$28.805
Effect of exchange rate $0.302 -$5.561 $0.982
Change in cash and equivalents $1.048 -$28.047 $8.29

ADOM
Envirotech Vehicles Inc
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 29 Sep 2021 29 Jun 2021 30 Mar 2021
Current assets
Cash $10.580468 $8.287286 $8.255333
Short term investments $7.007 $12.01019
Net receivables $0.74664 $0.159177 $0.164197
Inventory $1.019453 $1.86032 $0.983025
Other current assets $0.060018 $0.254913 $0.273112
Total current assets $24.31665 $25.841255 $10.647822
Long term investments
Property, plant & equipment $0.465844 $0.441049 $0.446889
Goodwill $49.54691 $49.54691 $49.54691
Intangible assets
Other assets $0.138345 $0.206083 $0.041856
Total assets $74.467749 $76.035297 $60.683477
Current liabilities
Accounts payable $0.166282 $0.234357 $0.14234
Short long term debt $0.031788 $0.298747 $0.404203
Other current liabilities
Total current liabilities $1.062615 $1.566095 $1.869441
Long term debt $0.021192 $0.045298 $0.013511
Other liabilities $0.308649
Minority interest
Total liabilities $1.119046 $2.00028 $2.045858
Stockholders' equity
Common stock $0.002943 $0.00294 $0.002552
Retained earnings -$2.874324 -$2.023849 -$1.13077
Treasury stock
Capital surplus $76.220084 $76.055926 $59.765837
Total stockholder equity $73.348703 $74.035017 $58.637619
Net tangible assets $23.801793 $24.488107 $9.090709
(in millions USD) 2020 2019 2018
Current assets
Cash $1.930132 $4.432 $3.759
Short term investments $2.771 $3.949
Net receivables $0.009 $0.701 $1.368
Inventory $0.494
Other current assets $0.041 $0.88405
Total current assets $1.939132 $9.636 $10.18
Long term investments
Property, plant & equipment $0.227561 $0.330504 $0.15
Goodwill
Intangible assets
Other assets $0.242025 $0.350496 $0.503
Total assets $2.408718 $10.317 $10.833
Current liabilities
Accounts payable $0.345383 $0.418 $0.342
Short long term debt
Other current liabilities $2.38266
Total current liabilities $2.728043 $6.887 $3.01
Long term debt $0.152835
Other liabilities $0.219
Minority interest
Total liabilities $2.880878 $7.035 $3.229
Stockholders' equity
Common stock $0.0001 $0.001 $0.001
Retained earnings -$0.47226 -$59.178 -$54.025
Treasury stock
Capital surplus $62.459 $61.628
Total stockholder equity -$0.47216 $3.282 $7.604
Net tangible assets -$0.47216 $3.282 $7.604

Income statement

XSLX
XSLX
(in millions USD) 29 Sep 2021 29 Jun 2021 30 Mar 2021
Revenue
Total revenue $0.709092 $0.188266 $0.470793
Cost of revenue $0.469611 $0.147932 $0.313434
Gross profit $0.239481 $0.040334 $0.157359
Operating activities
Research & development
Selling, general & administrative $1.381574 $0.931354 $0.596153
Total operating expenses $1.851185 $1.079286 $0.909587
Operating income -$1.142093 -$0.89102 -$0.438794
Income from continuing operations
Net other income $0.294018 -$0.002059 -$0.001416
EBIT -$1.142093 -$0.89102 -$0.438794
Income before tax -$0.848075 -$0.893079 -$0.44021
Income tax expense $0.0024 $0.2183
Minority interest
Net income
Net income -$0.850475 -$0.893079 -$0.65851
Income (for common shares) -$0.850475 -$0.893079 -$0.65851
(in millions USD) 2020 2019 2018
Revenue
Total revenue $0.088735 $12.561 $5.011
Cost of revenue $0.07709 $11.627 $4.878
Gross profit $0.011645 $0.934 $0.133
Operating activities
Research & development $0.109 $0.300935
Selling, general & administrative $0.402496 $6.038 $10.822
Total operating expenses $0.497395 $17.774 $16.000935
Operating income -$0.40866 -$5.213 -$10.989935
Income from continuing operations
Net other income $0.001839 $0.06 -$0.058065
EBIT -$0.40866 -$5.213 -$10.989935
Income before tax -$0.406821 -$5.153 -$11.048
Income tax expense -$0.1273
Minority interest
Net income
Net income -$0.279521 -$5.153 -$11.048
Income (for common shares) -$0.279521 -$5.153 -$11.048

Cash flows

XSLX
XSLX
(in millions USD) 29 Sep 2021 29 Jun 2021 30 Mar 2021
Net income -$0.850475 -$0.893079 -$0.65851
Operating activities
Depreciation $0.007655 $0.02738 $0.007996
Change in accounts receivable -$0.587463 $0.00502 -$0.151824
Changes in inventory $0.415857 -$0.877296 -$0.331361
Total cash flows from operations -$3.099861 -$3.921587 -$2.89588
Investing activities
Capital expenditures $0.155118 -$0.183076 -$0.183076
Investments $5 -$12 -$12
Other cash flows from investing $3.373332
Total cash flows from investing $5.155118 -$12.183076 $3.373332
Financing activities
Dividends paid
Net borrowings -$0.15703 -$0.152835
Other cash flows from financing -$0.031572 -$0.156443
Total cash flows from financing $0.043029 $16.133447 $6.105832
Effect of exchange rate
Change in cash and equivalents $2.098287 $0.028783 $6.583284
(in millions USD) 2020 2019 2018
Net income -$0.279521 -$5.153 -$11.048
Operating activities
Depreciation $0.01767 $0.048 $0.043
Change in accounts receivable -$0.009 $0.335 -$0.997
Changes in inventory -$0.494 $0.21
Total cash flows from operations $1.526333 -$4.582 -$4.511
Investing activities
Capital expenditures -$0.073091 -$0.013 -$0.079
Investments $1.179 -$3.926
Other cash flows from investing -$0.038 $0.3
Total cash flows from investing -$0.073091 $1.128 -$3.705
Financing activities
Dividends paid
Net borrowings $0.152835 $4.12 -$0.449
Other cash flows from financing -$0.109 -$1.121
Total cash flows from financing $0.152835 $4.127 $9.529
Effect of exchange rate
Change in cash and equivalents $1.606077 $0.673 $1.313

AEMD
Aethlon Medical Inc
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Current assets
Cash $9.19319 $5.562789 $8.092823 $10.296731
Short term investments
Net receivables
Inventory
Total current assets $9.550437 $6.225788 $8.249333 $10.487317
Long term investments
Property, plant & equipment $1.743206 $1.898283 $2.065346 $2.218826
Goodwill & intangible assets $0.000963 $0.0011 $0.001238 $0.001375
Total noncurrent assets $1.86498 $2.020194 $2.187395 $2.341012
Total investments
Total assets $11.415417 $8.245982 $10.436728 $12.828329
Current liabilities
Accounts payable $1.800652 $1.324296 $1.349199 $0.934723
Deferred revenue
Short long term debt $0.296093
Total current liabilities $2.128948 $1.829899 $2.100623 $1.710534
Long term debt $0.573852 $0.649751 $0.724848 $0.798451
Total noncurrent liabilities $0.573853 $0.649751 $0.724848 $0.798451
Total debt $0.869945 $0.649751 $0.724848 $0.798451
Total liabilities $2.702801 $2.47965 $2.825471 $2.508985
Stockholders' equity
Retained earnings -$157.138168 -$154.566728 -$152.141311 -$148.67519
Other stockholder equity -$0.007773 -$0.00694 -$0.001619 -$0.00957
Total stockholder equity $8.712616 $5.766332 $7.611257 $10.319344
(in millions USD) 2024 2023 2022
Current assets
Cash $5.562789 $14.653754 $17.19323
Short term investments
Net receivables $0.127965
Inventory
Total current assets $6.225788 $15.090566 $18.157007
Long term investments
Property, plant & equipment $1.898283 $2.295913 $1.137936
Goodwill & intangible assets $0.0011 $0.00165 $0.0022
Total noncurrent assets $2.020194 $2.418374 $1.260947
Total investments
Total assets $8.245982 $17.50894 $19.417954
Current liabilities
Accounts payable $1.324296 $0.647111 $0.655704
Deferred revenue $0.344547
Short long term debt
Total current liabilities $1.829899 $1.505089 $1.824049
Long term debt $0.649751 $0.939642 $0.602505
Total noncurrent liabilities $0.649751 $0.939642 $0.602505
Total debt $0.649751 $0.939642 $0.602505
Total liabilities $2.47965 $2.444731 $2.426554
Stockholders' equity
Retained earnings -$154.566728 -$142.358555 -$130.329181
Other stockholder equity -$0.00694 -$0.006141
Total stockholder equity $5.766332 $15.064209 $17.133108

Income statement

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Revenue
Total revenue
Cost of revenue
Gross profit
Operating activities
Research & development
Selling, general & administrative $0.751974 $0.764902 $0.979197 $0.850809
Total operating expenses $2.620858 $2.485974 $3.567088 $3.175346
Operating income -$2.620858 -$2.485974 -$3.567088 -$3.175346
Income from continuing operations
EBIT -$2.57144 -$2.425418 -$3.466121 -$3.034456
Income tax expense
Interest expense
Net income
Net income -$2.57144 -$2.425418 -$3.466121 -$3.034456
Income (for common shares) -$2.57144 -$2.425418 -$3.466121 -$3.034456
(in millions USD) 2024 2023 2022
Revenue
Total revenue $0.574245 $0.294165
Cost of revenue
Gross profit $0.574245 $0.294165
Operating activities
Research & development
Selling, general & administrative $3.903191 $4.481303 $3.455222
Total operating expenses $12.636568 $12.472883 $10.71505
Operating income -$12.636568 -$11.898638 -$10.420885
Income from continuing operations
EBIT -$12.208174 -$12.029786 -$10.416091
Income tax expense
Interest expense
Net income
Net income -$12.208174 -$12.029786 -$10.416091
Income (for common shares) -$12.208174 -$12.029786 -$10.416091

Cash flows

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Net income -$2.57144 -$2.425418 -$3.466121 -$3.034456
Operating activities
Depreciation $0.08606 $0.084617 $0.090907 $0.092113
Business acquisitions & disposals
Stock-based compensation $0.139328 $0.13912 $0.572955 $0.257181
Total cash flows from operations -$1.747537 -$2.565442 -$2.377835 -$2.704146
Investing activities
Capital expenditures -$0.004907 -$0.008807 -$0.00677
Investments
Total cash flows from investing -$0.004907 -$0.008807 -$0.00677
Financing activities
Dividends paid
Sale and purchase of stock $5.384307 $0.049762 $0.186502
Net borrowings
Total cash flows from financing $5.379229 $0.042572 $0.177129 -$0.009843
Effect of exchange rate -$0.00129 -$0.002257 $0.005605 -$0.001055
Change in cash and equivalents $3.630402 -$2.530034 -$2.203908 -$2.721814
(in millions USD) 2024 2023 2022
Net income -$12.208174 -$12.029786 -$10.416091
Operating activities
Depreciation $0.3592 $0.2653 $0.154217
Business acquisitions & disposals
Stock-based compensation $1.21937 $1.051898 $0.750621
Total cash flows from operations -$10.12981 -$10.505128 -$9.767157
Investing activities
Capital expenditures -$0.250867 -$0.943109 -$0.349193
Investments
Total cash flows from investing -$0.250867 -$0.943109 -$0.349193
Financing activities
Dividends paid
Sale and purchase of stock $1.322383 $8.927211 $17.456092
Net borrowings
Total cash flows from financing $1.287605 $8.914718 $17.367974
Effect of exchange rate $0.002107 -$0.005957
Change in cash and equivalents -$9.090965 -$2.533519 $7.251624